[NKTR] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
08-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 7.26%
YoY- -111.31%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 21,585 28,330 48,847 23,315 1,087,717 34,589 32,768 -6.71%
PBT -158,968 -125,162 -79,856 -110,187 975,345 -59,772 -48,476 21.87%
Tax 100 357 144 -278 3,885 99 127 -3.90%
NP -159,068 -125,519 -80,000 -109,909 971,460 -59,871 -48,603 21.83%
Tax Rate - - - - -0.40% - - -
Total Cost 180,653 153,849 128,847 133,224 116,257 94,460 81,371 14.20%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -736.94 -443.06 -163.78 -471.41 89.31 -173.09 -148.32 30.61%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.85 -0.69 -0.45 -0.63 5.67 -0.39 -0.36 15.38%
EPS Diluted -0.85 -0.69 -0.45 -0.63 5.33 -0.39 -0.36 15.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.